Skip to main content
. 2016 Feb 19;11(2):e0149288. doi: 10.1371/journal.pone.0149288

Fig 8. Effect of rosuvastatin on HO activity and AAA severity.

Fig 8

No significant difference in HO activity between aortas from vehicle- (white squares) and rosuvastatin- (black squares) treated ApoE-/- mice were found 14 days post-Ang II infusion, but when grouped by severity, HO activity in aortas with type-2 expansions was significantly higher in rosuvastatin-treated mice. *p<0.05, n = 3 for each group.